Category: Hepatitis
Global Hepatitis
-
Zoonotic Disease Treatment Market by Disease Type (Rabies, Tuberculosis, Viral Hepatitis), Drug Class (Antibacterial Medication, Antibiotics) - Global Forecast 2024-2030
... expected to reach USD 42.99 billion in 2024, at a CAGR 5.45% to reach USD 59.18 billion by 2030. Global Zoonotic Disease Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-
... size was estimated at USD 3.53 billion in 2023 and expected to reach USD 3.71 billion in 2024, at a CAGR 5.48% to reach USD 5.13 billion by 2030.The hepatitis test solutions/ diagnosis are used ... Read More
-
Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 30.76 billion in 2024, at a CAGR 4.11% to reach USD 38.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Therapeutics ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Hepatitis Therapeutics Global Market Report 2024
... ProvidersCovering: Gilead Sciences Inc.; Bristol-Myers Squibb Co.; AbbVie Inc.; Merck & Co. Inc.; Johnson & Johnson Services Inc. Hepatitis Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Research Report 2024(Status and Outlook)
... performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 1161.93 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Hepatitis B Vaccines market covering ... Read More
-
Global Hepatitis A Vaccination Market Research Report 2024(Status and Outlook)
... HAV infection, Minimum age for HAV vaccination is 1 year. The Global Hepatitis A Vaccination Market Size was estimated at USD 754.91 million in 2023 and is projected to reach USD 860.20 million by 2029, ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
... 2028 The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. ... Read More
-
Human Vaccine Adjuvants Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The global human ... Read More
-
Liver Disease Diagnostics Market Forecasts to 2030 – Global Analysis By Disease Type (Viral Hepatitis, Alcoholic Liver Disease, Non-alcoholic Fatty Liver Disease (NAFLD), Liver Cancer and Other Disease Types), Technique (Endoscopy, Biopsy, Imaging Techniques, Laboratory Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography
... Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography According to Stratistics MRC, the Global Liver Disease Diagnostics Market is accounted for $40.32 billion in 2023 and ... Read More
-
Hepatitis B - Global Clinical Trials Review, 2023
... B Clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ... Read More
-
Hepatitis Drugs Global Market Report 2024
... 2) By Route Of Administration: Oral; Injection3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 4) By Application: Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis ECovering: Gilead Sciences Inc.; F. Hoffmann-La Roche ... Read More
-
Interferons Market Forecasts to 2030 – Global Analysis By Product (Interferon Gamma, Interferon Beta, Interferon Alpha and Other Products), Application (Multiple Sclerosis, Polycythemia Vera, Hepatitis C, Hepatitis B, Melanoma, Leukemia, AIDS, Kaposi Sarcoma, Renal Cell Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography
... Carcinoma, Chronic Granulomatous Disease (CGD) and Other Applications), End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies, Homecare and Other End Users) and By Geography According to Stratistics MRC, the Global Interferons Market is ... Read More
-
Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... liver. It is spread through contact with an infected person's blood or bodily fluids. Sexual contact, sharing needles or other drug injection equipment, or being exposed to blood or body fluids in a healthcare setting ... Read More
-
Hyperimmune Globulins Market Forecasts to 2030 – Global Analysis By Type (Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Rho(D) Immunoglobulins, Tetanus Immunoglobulins and Other Types), By End User (Hospitals & Clinics, Blood Banks and Donation Centers, Government Institutions and Other End Users) and By Geography
... Institutions and Other End Users) and By Geography According to Stratistics MRC, the Global Hyperimmune Globulins Market is accounted for $2.01 billion in 2023 and is expected to reach $3.69 billion by 2030 growing at ... Read More
-
Travel Vaccines Global Market Report 2023 Including: 1) By Disease: Hepatitis A; Diphtheria, Pertussis, And Tetanus (DPT); Yellow Fever; Typhoid; Hepatitis B; Measles And Mumps; Rabies; Meningococcal; 2) By Composition: Mono Vaccines; Combination Vaccines 3) By Booking Channel: Online Booking; In-Person Booking 4) By Application: Domestic Travel; Outbound Travel Covering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA
... Channel: Online Booking; In-Person Booking4) By Application: Domestic Travel; Outbound TravelCovering: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA Travel Vaccines Global Market Report 2023 from The Business Research Company ... Read More
-
Global Hepatitis B Virus Panel Rapid Test Kit Market Growth 2023-2029
... in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Hepatitis B Virus Panel Rapid Test Kit is forecast to a readjusted size of US$ million ... Read More
-
Global Non-alcoholic Steatohepatitis Market 2023-2027
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Vaccine Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... been substantial progress in the availability of critical public health vaccinations during the previous two decades. New vaccinations have been developed and distributed globally, saving many lives and preventing illness. However, a thorough examination of ... Read More
-
Global Hepatitis B Treatment Market - 2023-2030
... the forecast period 2023-2030. The global Hepatitis B treatment market is trending towards current and innovative modalities for the management of chronic Hepatitis B infection. For instance, according to the World Journal of Hepatology, published ... Read More
-
Hepatitis B Diagnostic Test Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type
... and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is ... Read More
-
Enteric Disease Testing Market Forecasts to 2030 – Global Analysis By Pathogen (Campylobacter, Clostridium, E. coli, Enterobacteriaceae, Hepatitis A, B, and E, Listeria, Norovirus, Rotavirus, Salmonella, Shigella, Vibrio and Other Pathogens), Technology (Traditional, Rapid, Convenience Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography & Spectrometry and Other Technologies), End User and By Geography
... Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography & Spectrometry and Other Technologies), End User and By Geography According to Stratistics MRC, the Global Enteric Disease Testing Market is accounted for $4.18 billion in 2023 and ... Read More
-
Immunodiagnostics Market Forecast to 2030 - COVID-19 Impact and Global Analysis by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others), and Geography
... User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others), and Geography The immunodiagnostics market size is expected to reach US$ 34,487.80 million by 2030 from US$ 19,218.89 million in 2022; it is estimated ... Read More
Research Assistance
